Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Liu, C., Bayer, A. S., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,211 · see citing works

Waves of resistance: Staphylococcus aureus in the antibiotic era

Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718 · see citing works

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>

Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459 · see citing works

Reduced Vancomycin Susceptibility in <i>Staphylococcus aureus</i> , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962 · see citing works

High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections

Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong‐Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 859 · see citing works

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Sakoulas, G., Moise-Broder, P. A., Schentag, J. J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 834 · see citing works

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

Soriano, À., Marco, F., Martínez, J. A., Pisos, E., Almela, M., Dimova, V., Alamo, D., Ortega, M., Lopez, J., & Mensa, J. (2007) · Clinical Infectious Diseases · doi:10.1086/524667 · Cited by 767 · see citing works

Antibiotic resistance is prevalent in an isolated cave microbiome

Bhullar, K., Waglechner, N., Pawlowski, A., Koteva, K., Banks, E. D., Johnston, M. D., Barton, H. A., & Wright, G. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034953 · Cited by 736 · see citing works

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

Lodise, T. P., Graves, J. P., Evans, A. M., Graffunder, E. M., Helmecke, M. R., Lomaestro, B. M., & Stellrecht, K. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-08 · Cited by 551 · see citing works

Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing

Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de LENCASTRE, H., Richardson, P., Bruce, D. G., Rubin, E. M., Myers, E. W., Siggia, E. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609839104 · Cited by 538 · see citing works

Two‐component system VraSR positively modulates the regulation of cell‐wall biosynthesis pathway in Staphylococcus aureus

Kuroda, M., Kuroda, H., Oshima, T., Takeuchi, F., Mori, H., & Hiramatsu, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03599.x · Cited by 515 · see citing works

A Cholesterol Biosynthesis Inhibitor Blocks <i>Staphylococcus aureus</i> Virulence

Liu, C.-I., Liu, G. Y., Song, Y., Yin, F., Hensler, M. E., Jeng, W.-Y., Nizet, V., Wang, A. H.-J., & Oldfield, E. (2008) · Science · doi:10.1126/science.1153018 · Cited by 490 · see citing works

Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus

Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454 · see citing works

Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides

Straus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446 · see citing works

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

Cui, L., Tominaga, E., Neoh, H., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1079-1082.2006 · Cited by 427 · see citing works

Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR

Howden, B. P., McEvoy, C. R. E., Allen, D. L., Chua, K., Gao, W., Harrison, P. F., Bell, J. M., Coombs, G. W., Bennett-Wood, V. R., Porter, J. L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002359 · Cited by 371 · see citing works

The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion

Ernst, C. M., Neumann‐Staubitz, P., Mishra, N. N., Yang, S. J., Hornig, G., Kalbacher, H., Bayer, A. S., Kraus, D., & Peschel, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000660 · Cited by 370 · see citing works

New Insights into the WalK/WalR (YycG/YycF) Essential Signal Transduction Pathway Reveal a Major Role in Controlling Cell Wall Metabolism and Biofilm Formation inStaphylococcus aureus

Dubrac, S., Boneca, I. G., Poupel, O., & Msadek, T. (2007) · Journal of Bacteriology · doi:10.1128/jb.00645-07 · Cited by 347 · see citing works

Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon

Utaida, S., Dunman, P. M., Macapagal, D., Murphy, E., Projan, S. J., Singh, V. K., Jayaswal, R. K., & Wilkinson, B. J. (2003) · Microbiology · doi:10.1099/mic.0.26426-0 · Cited by 328 · see citing works

Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding

Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S., Proctor, R. A., Sahl, H., Schrenzel, J., Xiong, Y. Q., & Bayer, A. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-07 · Cited by 320 · see citing works

A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway

Dubrac, S., Bisicchia, P., Devine, K. M., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06483.x · Cited by 308 · see citing works

Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin

Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 298 · see citing works

Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells

Mascio, C. T. M., Alder, J. D., & Silverman, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00824-07 · Cited by 276 · see citing works

A widespread family of bacterial cell wall assembly proteins

Kawai, Y., Marles‐Wright, J., Cleverley, R. M., Emmins, R., Ishikawa, S., Kuwano, M., Heinz, N., Bui, N. K., Hoyland, C. N., Ogasawara, N., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.358 · Cited by 275 · see citing works

Daptomycin: mechanisms of action and resistance, and biosynthetic engineering

Baltz, R. H. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.02.031 · Cited by 266 · see citing works

Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin

Sakoulas, G., Alder, J. D., Thauvin-Eliopoulos, C., Moellering, R. C., & Eliopoulos, G. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1581-1585.2006 · Cited by 262 · see citing works

Human β-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci

Sass, V., Schneider, T., Wilmes, M., Körner, C., Tossi, A., Novikova, N. S., Валерьевна, Ш. О., & Sahl, H. (2010) · Infection and Immunity · doi:10.1128/iai.00688-09 · Cited by 254 · see citing works

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

Dhand, A., Bayer, A. S., Pogliano, J., Yang, S.-J., Bolaris, M., Nizet, V., Wang, G., & Sakoulas, G. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir340 · Cited by 252 · see citing works

Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus

Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241 · see citing works

Broad‐spectrum antimicrobial peptide resistance by MprF‐mediated aminoacylation and flipping of phospholipids

Ernst, C. M., & Peschel, A. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07576.x · Cited by 238 · see citing works

Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus

Peleg, A. Y., Miyakis, S., Ward, D. V., Earl, A. M., Rubio, A., Cameron, D. R., Pillai, S. K., Moellering, R. C., & Eliopoulos, G. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028316 · Cited by 237 · see citing works

Vancomycin-Resistant Staphylococcus aureus--Pennsylvania, 2002

(2002) · JAMA · doi:10.1001/jama.288.17.2116 · Cited by 234 · see citing works

Identification of Genes Controlled by the Essential YycG/YycF Two-Component System ofStaphylococcus aureus

Dubrac, S., & Msadek, T. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.4.1175-1181.2004 · Cited by 229 · see citing works

Functional interaction of human neutrophil peptide‐1 with the cell wall precursor lipid II

de Leeuw, E., Li, C., Zeng, P., Li, C., Bruin, M. D.-D., Lu, W., Breukink, E. J., & Lu, W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.004 · Cited by 222 · see citing works

Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus

Mishra, N. N., Yang, S., Sawa, A., Rubio, A., Nast, C. C., Yeaman, M. R., & Bayer, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01682-08 · Cited by 216 · see citing works

A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐Resistant<i>Staphylococcus aureus</i>Disease in San Francisco, 2004–2005

Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587893 · Cited by 205 · see citing works

Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane Depolarization

Muthaiyan, A., Silverman, J. A., Jayaswal, R. K., & Wilkinson, B. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01121-07 · Cited by 205 · see citing works

Carotenoid-Related Alteration of Cell Membrane Fluidity Impacts Staphylococcus aureus Susceptibility to Host Defense Peptides

Mishra, N. N., Liu, G. Y., Yeaman, M. R., Nast, C. C., Proctor, R. A., McKinnell, J. A., & Bayer, A. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00680-10 · Cited by 204 · see citing works

Overexpression of Genes of the Cell Wall Stimulon in Clinical Isolates ofStaphylococcus aureusExhibiting Vancomycin-Intermediate-S. aureus-Type Resistance to Vancomycin

McAleese, F., Wu, S. W., Sieradzki, K., Dunman, P. M., Murphy, E., Projan, S. J., & Tomasz, A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.3.1120-1133.2006 · Cited by 196 · see citing works

The Virulence Regulator Sae of Staphylococcus aureus: Promoter Activities and Response to Phagocytosis-Related Signals

Geiger, T., Goerke, C., Mainiero, M., Kraus, D., & Wolz, C. (2008) · Journal of Bacteriology · doi:10.1128/jb.01927-07 · Cited by 192 · see citing works

Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action.

Yeaman, M. R., Bayer, A. S., Koo, S.-P., Foss, W. M., & Sullam, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci562 · Cited by 189 · see citing works

Influence of the Two-Component System SaeRS on Global Gene Expression in Two Different Staphylococcus aureus Strains

Rogasch, K., Rühmling, V., Pané‐Farré, J., Höper, D. W., Weinberg, C., Fuchs, S., Schmudde, M., Bröker, B. M., Wolz, C., Hecker, M., et al. (2006) · Journal of Bacteriology · doi:10.1128/jb.00555-06 · Cited by 188 · see citing works

An Association between Reduced Susceptibility to Daptomycin and Reduced Susceptibility to Vancomycin in Staphylococcus aureus

Patel, J. B., Jevitt, L. A., Hageman, J. C., McDonald, L. C., & Tenover, F. C. (2006) · Clinical Infectious Diseases · doi:10.1086/504084 · Cited by 183 · see citing works

The Lipopeptide Antibiotic Friulimicin B Inhibits Cell Wall Biosynthesis through Complex Formation with Bactoprenol Phosphate

Schneider, T., Gries, K., Josten, M., Wiedemann, I., Pelzer, S., Labischinski, H., & Sahl, H. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01040-08 · Cited by 182 · see citing works

A Very Early-Branching Staphylococcus aureus Lineage Lacking the Carotenoid Pigment Staphyloxanthin

Holt, D. C., Holden, M. T. G., Tong, S. Y. C., Castillo‐Ramírez, S., Clarke, L., Quail, M. A., Currie, B. J., Parkhill, J., Bentley, S. D., Feil, E. J., et al. (2011) · Genome Biology and Evolution · doi:10.1093/gbe/evr078 · Cited by 173 · see citing works

Intramembrane-sensing histidine kinases: a new family of cell envelope stress sensors in Firmicutes bacteria

Mascher, T. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00444.x · Cited by 171 · see citing works

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

Lunde, C. S., Hartouni, S. R., Janc, J. W., Mammen, M., Humphrey, P. P. A., & Benton, B. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-08 · Cited by 171 · see citing works

Genetic Analysis of Factors Affecting Susceptibility ofBacillus subtilisto Daptomycin

Hachmann, A., Angert, E. R., & Helmann, J. D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01329-08 · Cited by 168 · see citing works

Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032

Allen, N. E., Hobbs, J. N., & Alborn, W. E. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1093 · Cited by 152 · see citing works

Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years

Musta, A. C., RIEDERER, K. M., Shemes, S. P., Chase, P., Jose, J., Johnson, L. B., & Khatib, R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02135-08 · Cited by 152 · see citing works

Synergy of Daptomycin with Oxacillin and Other β-Lactams against Methicillin-Resistant Staphylococcus aureus

Rand, K. H., & Houck, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2871-2875.2004 · Cited by 151 · see citing works

In Vitro Resistance of <i>Staphylococcus aureus</i> to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Alterations in Cytoplasmic Membrane Fluidity

Bayer, A. S., Prasad, R., Chandra, J., Koul, A., Smriti, M., Varma, A., Skurray, R. A., Firth, N., Brown, M. H., Koo, S.-P., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3548-3553.2000 · Cited by 150 · see citing works

Oligomerization of daptomycin on membranes

Muraih, J. K., Pearson, A. L., Silverman, J. A., & Palmer, M. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.01.001 · Cited by 149 · see citing works

Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)

Canepari, P., Boaretti, M., Lleò, M. M., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1220 · Cited by 148 · see citing works

Molecular Architecture of the Regulatory Locus sae of Staphylococcus aureus and Its Impact on Expression of Virulence Factors

Steinhuber, A., Goerke, C., Bayer, M. G., et al. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.21.6278-6286.2003 · Cited by 142 · see citing works

Reduction in Membrane Phosphatidylglycerol Content Leads to Daptomycin Resistance in Bacillus subtilis

Hachmann, A., Sevi̇m, E., Gaballa, A., Popham, D. L., Antelmann, H., & Helmann, J. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01819-10 · Cited by 142 · see citing works

Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureus

Yang, S., Kreiswirth, B. N., Sakoulas, G., Yeaman, M. R., Xiong, Y.-Q., Sawa, A., & Bayer, A. S. (2009) · The Journal of Infectious Diseases · doi:10.1086/648473 · Cited by 135 · see citing works

Synthesis and Derivatization of Daptomycin: A Chemoenzymatic Route to Acidic Lipopeptide Antibiotics

Grünewald, J., Sieber, S. A., Mahlert, C., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja045455t · Cited by 134 · see citing works

In Vitro Cross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

Mishra, N. N., McKinnell, J. A., Yeaman, M. R., Rubio, A., Nast, C. C., Chen, L., Kreiswirth, B. N., & Bayer, A. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00223-11 · Cited by 134 · see citing works

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

Sakoulas, G., Eliopoulos, G. M., Alder, J. D., & Eliopoulos, C. T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1714-1718.2003 · Cited by 134 · see citing works

Subinhibitory concentrations of β-lactam induce haemolytic activity inStaphylococcus aureusthrough the SaeRS two-component system

Kuroda, H., Kuroda, M., Cui, L., et al. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00568.x · Cited by 128 · see citing works

Correlation of Daptomycin Resistance in a Clinical Staphylococcus aureus Strain with Increased Cell Wall Teichoic Acid Production and d -Alanylation

Bertsche, U., Weidenmaier, C., Kuehner, D., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01226-10 · Cited by 128 · see citing works

Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus

Cotroneo, N. S., Harris, R. J., Perlmutter, N. G., Beveridge, T. J., & Silverman, J. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01410-07 · Cited by 127 · see citing works

Evidence that the Essential Response Regulator YycF inStreptococcus pneumoniaeModulates Expression of Fatty Acid Biosynthesis Genes and Alters Membrane Composition

Mohedano, M. L., Overweg, K., de la Fuente, A., Reuter, M., Altabe, S., Mulholland, F., de Mendoza, D., López, P., & Wells, J. M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2357-2367.2005 · Cited by 119 · see citing works

Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis

Julian, K. G., Kosowska-Shick, K., Whitener, C., Roos, M. A., Labischinski, H., Rubio, A., Parent, L. J., Ednie, L. M., Koeth, L. M., Bogdanovich, T., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00559-07 · Cited by 119 · see citing works

Attachment of Capsular Polysaccharide to the Cell Wall in Streptococcus pneumoniae

Eberhardt, A., Hoyland, C. N., Vollmer, D., Bisle, S., Cleverley, R. M., Johnsborg, O., Håvarstein, L. S., Lewis, R. J., & Vollmer, W. (2012) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0232 · Cited by 114 · see citing works

Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus : Evidence for Multiple Resistance Mechanisms

Yang, S., Nast, C. C., Mishra, N. N., Yeaman, M. R., Fey, P. D., & Bayer, A. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00122-10 · Cited by 114 · see citing works

Effect of divalent cations on the structure of the antibiotic daptomycin

Ho, S. W., Jung, D., Calhoun, J. R., et al. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0227-2 · Cited by 112 · see citing works

Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus

Jansen, A., Türck, M., Szekat, C., Nagel, M., Clever, I., & Bierbaum, G. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.02.002 · Cited by 108 · see citing works

Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach

Fischer, A., Yang, S., Bayer, A. S., Vaezzadeh, A. R., Herzig, S., Stenz, L., Girard, M., Sakoulas, G., Scherl, A., Yeaman, M. R., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr195 · Cited by 104 · see citing works

Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains

Yang, S., Xiong, Y. Q., Dunman, P. M., Schrenzel, J., François, P., Peschel, A., & Bayer, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01415-08 · Cited by 101 · see citing works

Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia

Haque, N. Z., Cahuayme‐Zuniga, L., Peyrani, P., Reyes, K., Lamerato, L. E., Moore, C. L., Patel, S., Allen, M., Peterson, E. L., Wiemken, T. L., et al. (2010) · CHEST Journal · doi:10.1378/chest.09-2453 · Cited by 101 · see citing works

Multiple Peptide Resistance Factor (MprF)-mediated Resistance of Staphylococcus aureus against Antimicrobial Peptides Coincides with a Modulated Peptide Interaction with Artificial Membranes Comprising Lysyl-Phosphatidylglycerol

Andrä, J., Goldmann, T., Ernst, C. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226886 · Cited by 98 · see citing works

Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Tong, S. Y. C., Chen, L. F., & Fowler, V. G. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0300-x · Cited by 97 · see citing works

Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 μg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis

Maclayton, D. O., Suda, K. J., Coval, K. A., York, C. B., & Garey, K. W. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.003 · Cited by 97 · see citing works

In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria

Krause, K. M., Renelli, M., Difuntorum, S., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01398-07 · Cited by 97 · see citing works

Adjunctive Rifampin Is Crucial to Optimizing Daptomycin Efficacy against Rabbit Prosthetic Joint Infection Due to Methicillin-Resistant Staphylococcus aureus

Saleh‐Mghir, A., Muller‐Serieys, C., Dinh, A., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00675-11 · Cited by 96 · see citing works

High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia

Sharma, M., RIEDERER, K. M., Chase, P., et al. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0455-5 · Cited by 94 · see citing works

Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies

Steenbergen, J. N., Mohr, J., & Thorne, G. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp346 · Cited by 94 · see citing works

Characterization of daptomycin oligomerization with perylene excimer fluorescence: Stoichiometric binding of phosphatidylglycerol triggers oligomer formation

Muraih, J. K., Harris, J., Taylor, S. D., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.10.027 · Cited by 93 · see citing works

A sensor histidine kinase co‐ordinates cell wall architecture with cell division in Bacillus subtilis

Fukushima, T., Szurmant, H., Kim, E., Perego, M., & Hoch, J. A. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06308.x · Cited by 93 · see citing works

Causal Role of Single Nucleotide Polymorphisms within the mprF Gene of Staphylococcus aureus in Daptomycin Resistance

Yang, S., Mishra, N. N., Rubio, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01184-13 · Cited by 93 · see citing works

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin

Yoon, Y. K., Kim, J., Park, D. W., Sohn, J. W., & Kim, M. J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq050 · Cited by 93 · see citing works

Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs

Sacks‐Davis, R., Daraganova, G., Aitken, C. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047335 · Cited by 92 · see citing works

Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

Rose, W. E., Leonard, S. N., & Rybak, M. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00102-08 · Cited by 90 · see citing works

Peptidoglycan Crosslinking Relaxation Plays an Important Role in Staphylococcus aureus WalKR-Dependent Cell Viability

Delauné, A., Poupel, O., Mallet, A., Coïc, Y., Msadek, T., & Dubrac, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017054 · Cited by 88 · see citing works

Lysyl-Phosphatidylglycerol Attenuates Membrane Perturbation Rather than Surface Association of the Cationic Antimicrobial Peptide 6W-RP-1 in a Model Membrane System: Implications for Daptomycin Resistance

Kilelee, E. M., Pokorny, A., Yeaman, M. R., & Bayer, A. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00191-10 · Cited by 85 · see citing works

Plasmid-Mediated Resistance to Thrombin-Induced Platelet Microbicidal Protein in Staphylococci: Role of the qacA Locus

Kupferwasser, L. I., Skurray, R. A., Brown, M. H., Firth, N., Yeaman, M. R., & Bayer, A. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2395 · Cited by 85 · see citing works

Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia

Choi, E. Y., Huh, J. W., Lim, C., et al. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2130-7 · Cited by 83 · see citing works

Daptomycin Nonsusceptibility in Staphylococcus aureus with Reduced Vancomycin Susceptibility Is Independent of Alterations in MprF

Pillai, S. K., Gold, H. S., Sakoulas, G., Wennersten, C. B., Moellering, R. C., & Eliopoulos, G. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00202-07 · Cited by 82 · see citing works

Mechanisms of daptomycin resistance in Staphylococcus aureus

Kaatz, G. W., Lundstrom, T. S., & Seo, S. M. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.05.030 · Cited by 80 · see citing works

Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate

Murthy, M. H., Olson, M. E., Wickert, R. W., et al. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.2008/000588-0 · Cited by 79 · see citing works

Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies

Rose, W. E., Rybak, M. J., & Kaatz, G. W. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm170 · Cited by 78 · see citing works

NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles

Scott, W. R. P., Baek, S. B., Jung, D., Hancock, R. E. W., & Straus, S. K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.034 · Cited by 78 · see citing works

Daptomycin versus Friulimicin B: In-Depth Profiling of Bacillus subtilis Cell Envelope Stress Responses

Wecke, T., Zühlke, D., Mäder, U., Jordan, S., Voigt, B., Pelzer, S., Labischinski, H., Homuth, G., Hecker, M., & Mascher, T. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01046-08 · Cited by 77 · see citing works

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

Wang, J., Wang, J., Sheng, W., Chen, Y., & Chang, S. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-159 · Cited by 76 · see citing works

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections

Neoh, H., Hori, S., Komatsu, M., Oguri, T., Takeuchi, F., Cui, L., & Hiramatsu, K. (2007) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-6-13 · Cited by 76 · see citing works

Efficacy of Telavancin in a Rabbit Model of Aortic Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus or Vancomycin-Intermediate Staphylococcus aureus

Madrigal, A. G., Basuino, L., & Chambers, H. F. “. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3163-3165.2005 · Cited by 76 · see citing works

Mode of action of human β-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge

Sass, V., Pag, U., Tossi, A., Bierbaum, G., & Sahl, H. (2008) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2008.01.011 · Cited by 74 · see citing works

Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection

Cirioni, O., Mocchegiani, F., Ghiselli, R., et al. (2010) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2010.08.009 · Cited by 71 · see citing works

Clinical Progression of Methicillin-Resistant Staphylococcus aureus Vertebral Osteomyelitis Associated with Reduced Susceptibility to Daptomycin

Vikram, H. R., Havill, N. L., Koeth, L. M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5384-5387.2005 · Cited by 71 · see citing works

Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis

Lefebvre, M., Jacqueline, C., Amador, G., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.07.008 · Cited by 65 · see citing works

Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical Methicillin-Resistant Staphylococcus aureus Isolates Obtained before and after Daptomycin Treatment Failure

Boyle‐Vavra, S., Jones, M. B., Gourley, B. L., Holmes, M. H., Ruf, R. A. S., Balsam, A. R., Boulware, D. R., Kline, S., Jawahir, S., DeVries, A., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01593-10 · Cited by 64 · see citing works

Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response

Haunreiter, V. D., Meier, P. S., Heusser, R., Kupferschmied, P., Fazekas, J., Friebe, S., Staufer, S. B., Majcherczyk, P. A., Moreillon, P., Berger‐Bächi, B., et al. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02603.x · Cited by 60 · see citing works

Chemoenzymatic Design of Acidic Lipopeptide Hybrids: New Insights into the Structure−Activity Relationship of Daptomycin and A54145

Kopp, F. B., Grünewald, J., Mahlert, C., et al. (2006) · Biochemistry · doi:10.1021/bi0609422 · Cited by 59 · see citing works

The Mevalonate Pathway ofStaphylococcus aureus

Balibar, C. J., Shen, X., & Tao, J. (2008) · Journal of Bacteriology · doi:10.1128/jb.01357-08 · Cited by 59 · see citing works

Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic Patients

Mishra, N. N., Bayer, A. S., Moise, P. A., Yeaman, M. R., & Sakoulas, G. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis482 · Cited by 56 · see citing works

Low-Level Resistance of Staphylococcus aureus to Thrombin-Induced Platelet Microbicidal Protein 1 In Vitro Associated with qacA Gene Carriage Is Independent of Multidrug Efflux Pump Activity

Bayer, A. S., Kupferwasser, L. I., Brown, M. H., Skurray, R. A., Grkovic, S., Jones, T., Mukhopadhay, K., & Yeaman, M. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00028-06 · Cited by 51 · see citing works

Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus

Patel, D., Husain, M., Vidaillac, C., et al. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.06.010 · Cited by 50 · see citing works

Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus

Miró, J. M., García-de-la-Mària, C., Armero, Y., de Lazzari, E., Soy, D., Moreno, A., del Rı́o, A., Almela, M., Mestres, C. A., Gatell, J. M., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01266-06 · Cited by 45 · see citing works

Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis

Chambers, H. F., Basuino, L., Diep, B. A., Steenbergen, J., Zhang, S., Tattevin, P., & Alder, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01307-08 · Cited by 42 · see citing works

Regulation of mprF by Antisense RNA Restores Daptomycin Susceptibility to Daptomycin-Resistant Isolates of Staphylococcus aureus

Rubio, A., Conrad, M. C., Haselbeck, R. J., Kedar, G. C., Brown‐Driver, V., Finn, J., & Silverman, J. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00429-10 · Cited by 42 · see citing works

Successful Treatment of Vancomycin-Intermediate Staphylococcus aureus Pacemaker Lead Infective Endocarditis with Telavancin

Marcos, L. A., & Camins, B. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00857-10 · Cited by 39 · see citing works

Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies

Song, Y., Lunde, C. S., Benton, B. M., & Wilkinson, B. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05403-11 · Cited by 38 · see citing works

Changing the phospholipid composition of Staphylococcus aureus causes distinct changes in membrane proteome and membrane‐sensory regulators

Sievers, S., Ernst, C. M., Geiger, T., Hecker, M., Wolz, C., Becher, D., & Peschel, A. (2010) · PROTEOMICS · doi:10.1002/pmic.200900772 · Cited by 37 · see citing works

Effect of lipoteichoic acid on thermotropic membrane properties

Gutberlet, T., Frank, J., Bradaczek, H., et al. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.9.2879-2883.1997 · Cited by 34 · see citing works

Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)

Cunha, B. A., & Pherez, F. M. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0692-2 · Cited by 34 · see citing works

Evaluation of Ceftaroline Activity versus Daptomycin (DAP) against DAP-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Steed, M. E., Vidaillac, C., & Rybak, M. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00347-11 · Cited by 34 · see citing works

cwrA, a gene that specifically responds to cell wall damage in Staphylococcus aureus

Balibar, C. J., Shen, X., McGuire, D., et al. (2010) · Microbiology · doi:10.1099/mic.0.036129-0 · Cited by 33 · see citing works

Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure

Joson, J., Grover, C. A., Downer, C., Pujar, T., & Heidari, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr234 · Cited by 31 · see citing works

Inhibition of peptidoglycan biosynthesis in Bacillus megaterium by daptomycin

Mengin‐Lecreulx, D. (1990) · FEMS Microbiology Letters · doi:10.1016/0378-1097(90)90074-z · Cited by 28 · see citing works

Inhibition of peptidoglycan biosynthesis inBacillus megateriumby daptomycin

Mengin‐Lecreulx, D., Allen, N. E., Hobbs, J. N., et al. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb04238.x · Cited by 25 · see citing works

Evaluation of Telavancin Activity versus Daptomycin and Vancomycin against Daptomycin-Nonsusceptible Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Steed, M. E., Vidaillac, C., & Rybak, M. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05849-11 · Cited by 23 · see citing works

In vitro time–kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin

Vidaillac, C., Parra-Ruiz, J., & Rybak, M. J. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.09.002 · Cited by 23 · see citing works

Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections

Nadrah, K., & Strle, F. (2011) · Chemotherapy Research and Practice · doi:10.1155/2011/619321 · Cited by 21 · see citing works

Telavancin in Therapy of Experimental Aortic Valve Endocarditis in Rabbits Due to Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus

Xiong, Y. Q., Abdelhady, W., Bayer, A. S., Chen, L., Kreiswirth, B. N., & Yang, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00922-12 · Cited by 21 · see citing works

Mechanisms of Antibiotic Resistance

Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782 · see citing works

Mechanisms of antibiotic resistance

Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421 · see citing works

Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids

Tran, T. T., Panesso, D., Mishra, N. N., Mileykovskaya, E., Guan, Z., Munita, J. M., Reyes, J., Diaz, L., Weinstock, G. M., Murray, B. E., et al. (2013) · mBio · doi:10.1128/mbio.00281-13 · Cited by 192 · see citing works

A liaR Deletion Restores Susceptibility to Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis

Reyes, J., Panesso, D., Tran, T. T., Mishra, N. N., Cruz, M. R., Munita, J. M., Singh, K. V., Yeaman, M. R., Murray, B. E., Shamoo, Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu602 · Cited by 94 · see citing works

Natural products to drugs: daptomycin and related lipopeptide antibiotics

Baltz, R. H., Miao, V., & Wrigley, S. K. (2005) · Natural Product Reports · doi:10.1039/b416648p · Cited by 393 · see citing works

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

Steenbergen, J. N., Alder, J. D., Thorne, G. M., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 563 · see citing works

Biosynthesis and Genetic Engineering of Lipopeptide Antibiotics Related to Daptomycin

Baltz, R. H. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608784221497 · Cited by 61 · see citing works

Daptomycin, a Bacterial Lipopeptide Synthesized by a Nonribosomal Machinery

Robbel, L., & Marahiel, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.128181 · Cited by 206 · see citing works

NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles

Scott, W. R. P., Baek, S. B., Jung, D., Hancock, R. E. W., & Straus, S. K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.034 · Cited by 78 · see citing works